Skip to content

Sample Page

ViiV secures patents for key HIV drugs dolutegravir and cabotegravir opposed in India

February 11, 2016 by admin

Categories MSF in news, Uncategorized

Patient challenges patent on two key HIV drugs

MSF supports people living with HIV to oppose Viiv’s attempt to get patents for HIV drugs dolutegravir & cabotegravir

Leave a Comment Cancel reply

Comment

Name Email Website

Save my name, email, and website in this browser for the next time I comment.

Search

Recent Posts

Palestine: Israel’s threat to withhold registration for NGOs
Pakistan: Harsh winter worsens the Afghan refugee crisis amid forced deportations
South Sudan: MSF Evacuates Staff from Lankien Healthcare Facility Following Airstrikes
Indonesia: Flood and landslide emergency in Sumatra
Lebanon: Can a child with a crayon heal a community?

Recent Comments

No comments to show.

© 2026 msfsouthasia • Built with GeneratePress